Highest-materiality recent filing
Electromedical Technologies cancels prior share increase, approves 5B authorized shares
Board and majority shareholders approved on Aug 6, 2024 to increase authorized shares to 5,001,000,001.
ElectroMedical Tech boosts authorized shares to 3B common + 1M preferred
Board and majority shareholders approved charter amendment raising authorized shares to 3,001,000,001.
Electromedical Technologies auditor declines reelection; going concern noted; Hudgens appointed
dbbmckennon declined to stand for reelection as independent auditor on May 17, 2024; no disagreements or reportable events.
Electromedical settles defaults with Mast Hill Fund; cancels warrants, extends maturity
Settled defaults on three security purchase agreements dated Oct 2021, Feb 2022, and Sep 2022.
Electromedical sells headquarters property for $2M, leases it back for $9K/month
Sold real property at 16561 N. 92nd St., Scottsdale, AZ for $2,000,000. Net proceeds: $1,358,710.56.
Employment agreement gives Wolfson one Series B preferred share with voting control equal to all common shares plus 100k votes on fully diluted basis.
Director Lee Benson resigns over compensation policy disagreement
Lee Benson resigned as independent director on Dec 12, 2022, citing a disagreement with compensation policy.
CEO receives super-voting preferred shares, now controls 75.48% of voting power
Issued 500,000 Series A Preferred shares to CEO Matthew Wolfson as retention consideration; each share carries 100 votes.
ElectroMedical settles $668K debt with 26.7M shares to JR-HD Enterprises III
Settled five promissory notes totaling $617,353 principal + $51,017 accrued interest via restricted common stock.
Mast Hill Fund lends $500K (10% interest, OID $50K) and Talos Victory Fund $250K (10% interest, OID $25K); each convertible at $0.06/share.
On July 1, 2023, Robert L. Hymers, III resigned as an independent director of the Company.
On February 1, 2023, effective January 1, 2023, the Company appointed Robert L. Hymers, III, age 39, as an independent director and member of the compensation committee of the Company for a term of six months.
On December 20, 2022, the Company appointed Petar Gajic and Robert L. Hymers, III to the board of directors by written consent of the shareholder beneficially owning 60.04% of the votes eligible to be cast according to Sections 2.11 and 2.12(b) of the Company's By-Laws.
On December 20, 2022, the Company appointed Petar Gajic and Robert L. Hymers, III to the board of directors by written consent of the shareholder beneficially owning 60.04% of the votes eligible to be cast according to Sections 2.11 and 2.12(b) of the Company's By-Laws.
On December 12, 2022, Lee Benson resigned as an independent director of the Company.
On June 7, 2022, the registrant appointed Lee Benson, age 61, as an independent director of the Company.
Max materiality 0.80 · Median 0.60 · Most common event other_material